Ginsenoside chemotherapy

   
   

The invention provides for the use of ginsenoside Rh2 in pharmaceutical compositions used in methods of inhibiting the multiplication of cancer cells, and methods of treating cancer in patients, comprising administering to such patients therapeutically and synergistically effective amounts of Rh2 in combination with a chemotherapeutic selected from the group consisting of paclitaxel and mitoxantrone. The cancer cells to be treated may be multidrug resistant. The cancer cells may for example be prostate cancer cells or breast cancer cells.

A invenção fornece para o uso do ginsenoside Rh2 nas composições pharmaceutical usadas nos métodos de inibir a multiplicação de pilhas de cancer, e os métodos de tratar o cancer nos pacientes, compreendendo a administração a tais pacientes therapeutically e synergistically quantidades eficazes de Rh2 em combinação com um chemotherapeutic selecionado do paclitaxel e do mitoxantrone consistindo do grupo. As pilhas de cancer a ser tratadas podem ser multidrug resistente. As pilhas de cancer podem para o exemplo ser pilhas de cancer do prostate ou pilhas de cancer do peito.

 
Web www.patentalert.com

< Methods to treat undesirable immune responses

< Antidepressant drugs and methods

> Chimeric analgesic peptides

> Anti-inflammatory androstane derivative

~ 00118